amelioration of the symptoms of rodent disease models after transplantation of iPSC-derived
differentiated cells. For example, hematopoietic stem cells and neuronal precursor cells from …

Regenerative medicine is transitioning into clinical programs using stem/progenitor cell
therapies for repair of damaged organs. We summarize those for liver and pancreas, organs …

Human pluripotent stem cells have the potential to change the way in which human
diseases are cured. Clinical-grade human embryonic stem cells and human induced …

Alzheimer's disease (AD) places a heavy burden on the global economy. There is no
effective disease-modifying treatment available at present. Since the advent of induced …

We describe derivation of induced pluripotent stem cells (iPSCs) from terminally
differentiated mouse cells in serum-and feeder-free stirred suspension cultures. Temporal …

Pluripotent stem cell transplantation is a promising regenerative strategy for treating
intractable diseases. However, securing human leukocyte antigen (HLA)-matched donor …

Parthenogenesis and somatic cell nuclear transfer (SCNT) are two methods for deriving
embryonic stem (ES) cells that are genetically matched to the oocyte donor or somatic cell …

The discovery of induced pluripotent stem cells (iPSCs) and concurrent development of
protocols for their cell-type specific differentiation have revolutionized studies of diseases …

Although autologous induced pluripotent stem cells (iPSCs) can potentially be useful for
treating patients without immune rejection, in reality it will be extremely expensive and labor …

Human pluripotent stem cells (hPSCs) have practically unlimited proliferation potential and a
capability to differentiate into any cell type in the human body. Since the first derivation in …